✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Onesource Specialty Pharma Ltd.

ONESOURCE

Market Cap
₹19,319 Cr.
P/E
0.00

Onesource Specialty Pharma Ltd.

  • Onesource Specialty
  • Alembic Pharma
  • Astrazeneca Pharma I
FAQs on Onesource Specialty Pharma Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Onesource Specialty is 0

View FAQ's On Business
Growth Table
  • Onesource Specialty Pharma Ltd.
  • Alembic Pharma
  • Astrazeneca Pharma I
Balance Sheet
  • Onesource Specialty Pharma Ltd.
  • Alembic Pharma
  • Astrazeneca Pharma I
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Onesource Specialty Pharma Ltd.
  • Alembic Pharma
  • Astrazeneca Pharma I
Cash Flow
  • Onesource Specialty Pharma Ltd.
  • Alembic Pharma
  • Astrazeneca Pharma I
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Onesource Specialty Pharma Ltd.
  • Alembic Pharma
  • Astrazeneca Pharma I
Quarterly Results
  • Onesource Specialty Pharma Ltd.
  • Alembic Pharma
  • Astrazeneca Pharma I
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Onesource Specialty Pharma Ltd. Financials

Balance sheet of Onesource Specialty is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Onesource Specialty is increasing.
Latest net debt of Onesource Specialty is ₹471 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹442 Crs.

Yes, profit is increasing.
The profit of Onesource Specialty is -₹49.6 Crs for TTM, -₹391.17 Crs for Mar 2024 and -₹799.83 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Onesource Specialty latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech